Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 1.00 |
| ▸ | CA1 | P00915 | 11/20 | 1.00 |
| ▸ | CA12 | O43570 | 7/20 | 1.00 |
| ▸ | CA9 | Q16790 | 7/20 | 1.00 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.56 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12054668 | 0.83 | KEAP1 (0.75) | CA2CA1CA12CA9HTT | |
| SCHEMBL28472964 | 0.82 | CA2 (1.00) | CA2CA1CA12CA9CA4 | |
| SCHEMBL28014642 | 0.82 | CA12 (0.69) | CA2CA1CA12CA9HTT | |
| SCHEMBL5284646 | 0.79 | CA2 (0.66) | CA2CA1CA12CA9CA4 | |
| SCHEMBL8415404 | 0.78 | CA12 (0.64) | CA2CA1CA12CA9HTT | |
| SCHEMBL6401779 | 0.78 | CA12 (0.64) | CA2CA1CA12CA9HTT | |
| SCHEMBL6839436 | 0.78 | CA12 (0.64) | CA2CA1CA12CA9HTT | |
| SCHEMBL29080913 | 0.78 | CA2 (0.69) | CA2CA1CA12CA9CA4 | |
| SCHEMBL21104560 | 0.78 | CA2 (0.63) | CA2CA1CA12CA9CA4 | |
| SCHEMBL3521509 | 0.77 | CA2 (1.00) | CA2CA1CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1520324-A | Antiangiogenic combination thereapy for treatment of cancer | — | 2004-08-11 | — | — | CN | claimed |
| CN-118831076-A | Cannabinoid acid ester compositions and uses thereof | EPM (IP)公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-113840598-B | Cannabinoid acid ester compositions and uses thereof | EPM (IP)公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-1928925-B1 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | 3M INNOVATIVE PROPERTIES CO (US) | 2010-03-03 | — | — | EP | disclosed |
| US-7671154-B2 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671154-B2 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-03-02 | — | — | US | disclosed |
| US-20090215996-A1 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2009-08-27 | — | — | US | disclosed |
| US-20090215996-A1 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2009-08-27 | — | — | US | disclosed |
| US-7544755-B2 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-06-09 | — | — | US | disclosed |
| US-7544755-B2 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-06-09 | — | — | US | disclosed |
| US-20070078243-A1 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-05 | — | — | US | disclosed |
| US-20070078243-A1 | Crosslinked polymers with amine binding groups | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-05 | — | — | US | disclosed |
| US-20050130251-A1 | Reagent for determination of hydrogen peroxide | KYOWA MEDEX CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
| CN-1520324-A | Antiangiogenic combination thereapy for treatment of cancer | — | 2004-08-11 | — | — | CN | disclosed |
| EP-1424554-A1 | REAGENT FOR DETERMINING HYDROGEN PEROXIDE | KYOWA MEDEX CO., LTD. (JP) | 2004-06-02 | — | — | EP | disclosed |
| CN-1134410-C | Amine derivatives, process for their preparation and their use as antiarrhythmic agents | �й�ʯ����������ʯ�ͻ����������ι� | 2004-01-14 | — | — | CN | disclosed |
| CN-1169141-A | Novel amine derivatives, process for their preparation and their use as antiarrhythmic agents | C & C RESEARCH LABS (KR) | 1997-12-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215996-A1 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS | PAM, MSN, PARG | CA2 4183/4885CA1 2997/4885CA12 2789/4885 |
| US-20070078243-A1 | Crosslinked polymers with amine binding groups | PAM, MSN, PARG | CA2 4183/4885CA1 2997/4885CA12 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.